Literature DB >> 5571834

A combined clinical and histological assessment of survival of patients with Hodgkin's disease.

R M Cross, F W Dixon.   

Abstract

This paper reviews a series of 246 patients with Hodgkin's disease treated in the Royal Air Force Medical Service between 1940 and 1966. The clinical and histological staging of the disease in relation to the survival time is evaluated. The variation in the clinical patterns of the disease, together with the histological appearances in the affected glands, can be related to the patient's defence system. A most important clinical factor in assessing prognosis is considered to be the presence or absence of constitutional symptoms. The majority of the patients who had constitutional symptoms on presentation also had many glands involved. It was found in those patients who had no constitutional symptoms at the onset of the disease that there was little difference in survival time between those with glands involved in a single group or region and those with glands involved in many regions, whether above and/or below the diaphragm. Those patients with histologically well differentiated lesions showed a significantly higher survival rate than those in the histologically poorly differentiated groups.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5571834      PMCID: PMC477014          DOI: 10.1136/jcp.24.5.385

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  RELATIONSHIP OF HISTOLOGIC FEATURES TO CLINICAL STAGES IN HODGKIN'S DISEASE.

Authors:  R J LUKES
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1963-11

2.  HISTOLOGICAL CLASSIFICATION AND SURVIVAL IN HODGKIN'S DISEASE; A STUDY OF 251 CASES WITH SPECIAL REFERENCE TO NODULAR SCLEROSING HODGKIN'S DISEASE.

Authors:  T A HANSON
Journal:  Cancer       Date:  1964-12       Impact factor: 6.860

3.  A study of Hodgkin's disease treated by irradiation.

Authors:  M V PETERS; K C MIDDLEMISS
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1958-01

4.  Intensive cyclophosphamide therapy in advanced malignant disease.

Authors:  J H Binns; A C Southall
Journal:  Practitioner       Date:  1970-04

5.  Vascular invasion in Hodgkin's disease: its incidence and relationship to the spread of the disease.

Authors:  H Rappaport; S B Strum
Journal:  Cancer       Date:  1970-06       Impact factor: 6.860

6.  Hodgkin's disease: histological classification and diagnosis.

Authors:  R M Cross
Journal:  J Clin Pathol       Date:  1969-03       Impact factor: 3.411

7.  The pathology and nomenclature of Hodgkin's disease.

Authors:  R J Lukes; J J Butler
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

8.  Extended-field radical radiotherapy in advanced Hodgkin's disease: short-term results of 2 randomized clinical trials.

Authors:  H S Kaplan; S A Rosenberg
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

9.  Prophylactic treatment of adjacent areas in Hodgkin's disease.

Authors:  M V Peters
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

10.  Survey of the eventual diagnosis in 600 cases referred for a second histological opinion after an initial biopsy diagnosis of Hodgkin's disease.

Authors:  W S Symmers
Journal:  J Clin Pathol       Date:  1968-09       Impact factor: 3.411

  10 in total
  2 in total

1.  The significance of lymphocytic infiltration in neuroblastoma.

Authors:  I Lauder; W Aherne
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

2.  Hodgkin's disease. A clinico-pathological study of 250 cases with a 5-year follow-up.

Authors:  K A Newton; D H Mackenzie; M F Spittle; A Mikolajczuk
Journal:  Br J Cancer       Date:  1973-01       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.